These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22610592)

  • 1. Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.
    Lunder M; Ziberna L; Janić M; Jerin A; Skitek M; Sabovič M; Drevenšek G
    Heart Vessels; 2013 Mar; 28(2):246-54. PubMed ID: 22610592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats.
    Janic M; Lunder M; Cerne D; Marc J; Jerin A; Skitek M; Drevensek G; Sabovic M
    J Cardiovasc Pharmacol; 2016 Jul; 68(1):74-80. PubMed ID: 27010807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas.
    Lunder M; Drevenšek G; Černe D; Marc J; Janić M; Šabovič M
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):177-83. PubMed ID: 23091284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
    Janić M; Lunder M; France Štiglic A; Jerin A; Skitek M; Černe D; Marc J; Drevenšek G; Šabovič M
    Vascul Pharmacol; 2017 Dec; 99():45-52. PubMed ID: 28951255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts.
    Lunder M; Janić M; Žiberna L; Drevenšek G; Šabovič M
    Med Sci Monit; 2012 Sep; 18(9):BR366-74. PubMed ID: 22936187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Demirci B; McKeown PP; Bayraktutan U
    J Hypertens; 2005 Dec; 23(12):2219-27. PubMed ID: 16269964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin increases oxidative stress and modulates angiogenesis in Ossabaw swine with the metabolic syndrome.
    Elmadhun NY; Lassaletta AD; Chu LM; Liu Y; Feng J; Sellke FW
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1486-93. PubMed ID: 22995723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
    Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of nitrate tolerance by long-term treatment with statins.
    Fontaine D; Otto A; Fontaine J; Berkenboom G
    Cardiovasc Drugs Ther; 2003 Mar; 17(2):123-8. PubMed ID: 12975593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
    Bell RM; Yellon DM
    J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction.
    Gaur V; Kumar A
    Inflammopharmacology; 2011 Aug; 19(4):205-14. PubMed ID: 21061073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
    Castro MM; Rizzi E; Rascado RR; Nagassaki S; Bendhack LM; Tanus-Santos JE
    Eur J Pharmacol; 2004 Sep; 498(1-3):189-94. PubMed ID: 15363994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography.
    Filusch A; Buss S; Hardt S; Katus HA; Kuecherer HF; Hansen A
    Echocardiography; 2008 Oct; 25(9):974-81. PubMed ID: 18771549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of statins on endogenous H2S formation in perivascular adipose tissue.
    Wójcicka G; Jamroz-Wiśniewska A; Atanasova P; Chaldakov GN; Chylińska-Kula B; Bełtowski J
    Pharmacol Res; 2011 Jan; 63(1):68-76. PubMed ID: 20969959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of low-dose combination therapy with a statin and an angiotensin receptor blocker in a rat myocardial infarction model.
    Sohma R; Inoue T; Abe S; Taguchi I; Kikuchi M; Toyoda S; Arikawa T; Hikichi Y; Sanada S; Asanuma H; Kitakaze M; Node K
    J Cardiol; 2012 Jan; 59(1):91-6. PubMed ID: 21925839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of infarct size by short-term pretreatment with atorvastatin.
    Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
    Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T
    J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.